Sarepta Therapeutics, Inc. (NASDAQ:SRPT) shared an update on Elevidys (delandistrogene moxeparvovec-rokl), the only approved ...

Sangamo Therapeutics has stacked up $18 million cash from Eli Lilly in a licensing deal that will let the pharma use the ...

Bain Capital’s Life Sciences team led the funding round, with contributions from new investor Wellington Management.

Here is our list of the 11 Best Gene Therapy Stocks to Buy According to Analysts.

None of the cell and gene therapies that reached the final regulatory submission stage were rejected by the FDA.

Knocking out a single gene reprograms part of the large intestine to function like the nutrient-absorbing small intestine. In ...

Maria Lowe, Ph.D., associate vice president of Pharmaceutical Intelligence at Institute for Clinical and Economic Review ...

The $150 million will also go toward Atsena’s preclinical pipeline and expand the use of the biotech’s spreading AAV.SPR ...

In response to a request from the European Medicines Agency (EMA) following the death of a 16-year-old patient in the U.S., ...

Gene therapy, with its offer of a possible cure for rare diseases like sickle cell, is losing early investors to ...

Marks’ resignation leaves the field without a regulator many view as “integral” to its progress over the last decade.

Out of the shadows, new CDMO Artis BioSolutions has decloaked on a mission to tackle the tricky production process for ...